NS Bagirova1, AV Popa1, ТS Bogomolova2, NA Batmanova1, NV Dmitrieva1, IN Petukhova1, EN Sokolova1
1 NN Blokhin National Medical Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478
2 II Mechnikov North-Western State Medical University, 41 Kirochnaya str., Saint Petersburg, Russian Federation, 191015
For correspondence: Nataliya Sergeevna Bagirova, MD, PhD, 24 Kashirskoye sh., Moscow, Russian Federation, 115478; Tel.: 8(499)324-18-60; e-mail: email@example.com
For citation: Bagirova NS, Popa AV, Bogomolova ТS, et al. Aureobasidium pullulans-Associated Invasive Mycosis in a Child with Acute Myeloblastic Leukemia: A Case Report. Clinical oncohematology. 2018;11(3):259–64.
Severe mycotic infection occurring mainly in immunocompromised patients often exacerbates the progression of the primary oncohematological disease. It is the first attempt in Russian literature to present clinical and microbiological characteristics of invasive mycosis caused by Aureobasidium pullulans in a child with acute myeloblastic leukemia after receiving cytoreductive and antifungal treatment with favourable outcome.
Keywords: Aureobasidium pullulans, acute myeloblastic leukemia, invasive mycosis.
Received: January 15, 2018
Accepted: April 8, 2018Read in PDF
- Revankar SG, Sutton DA. Melanized Fungi in Human Disease. Clin Microbiol Rev. 2010;23(4):884–928. doi: 10.1128/CMR.00019-10.
- Hussain N, Revankar SG. Black Mold Infections: What We Know and What We Need to Know. Curr Clin Microbiol Rpt. 2017;4(2):106–11. doi: 10.1007/s40588-017-0062-x.
- Salkin IF, Martinez JA, Kemna ME. Opportunistic infection of the spleen caused by Aureobasidium pullulans. J Clin Microbiol. 1986;23(5):828–31.
- Najafzadeh MJ, Sutton DA, Keisari MS, et al. In Vitro Activities of Eight Antifungal Drugs against 104 Environmental and Clinical Isolates of Aureobasidium pullulans. Agents Chemother. 2014;58(9):5629–31. doi: 10.1128/AAC.03095-14.